
Aptus Pharma IPO Date, Review, Price, Allotment Details
Aptus Pharma IPO is offering its shares to the public for the first time through an IPO on the stock exchanges BSE SME. The total amount they aim to raise is 18,60,000 shares (aggregating up to ₹13.02 Cr). Out of this 17,66,000 shares (aggregating up to ₹12.36 Cr) will be through new shares, and [.] through existing shares. The IPO is open for subscription from 23 September, 2025 to 25 September, 2025. Each share has a face value of Rs 10, and investors can apply for shares at a price between ₹65 to ₹70 per share. The minimum number of shares one can apply for is 2000, or multiples of that as mentioned in the offer document.
Check Live IPO GMP List 👈
|
Check Live IPO Subscription List 👈
|
Check All IPO Allotment List 👈
|
Upcoming |
Aptus Pharma IPO Details
IPO Category Type: | SME |
IPO Open: | 23 September, 2025 |
IPO Close: | 25 September, 2025 |
IPO Price Band: | ₹65 to ₹70 per share |
Face Value: | ₹10 Per Equity Share |
IPO Listing on: | BSE SME |
IPO Issue Type: | Book Build Issue |
IPO Size: | Approx 18,60,000 shares (aggregating up to ₹13.02 Cr) |
Fresh Issue: | Approx 17,66,000 shares (aggregating up to ₹12.36 Cr) |
Offer for Sale: | Approx [.] |
Aptus Pharma IPO Reservation
Retail Quota: | 33.33% |
QIB Quota: | 47.31% |
NII Quota: | 14.30% |
Employee Discount: | [.] |
Aptus Pharma IPO Prospectus
DRHP Draft Prospectus: | Continue Reading |
RHP Draft Prospectus: | Continue Reading |
Anchor Investors List: | [.] |
Aptus Pharma IPO Market Lot Details
Application | Lot Size | Shares | Amount |
---|---|---|---|
1 | 2000 | ₹140000 |
Application | Lot Size | Shares | Amount |
---|---|---|---|
Individual investors (Retail) (Min) | 2 | 4000 | 280000 |
Individual investors (Retail) (Max) | 2 | 4000 | 280000 |
S-HNI (Min) | 3 | 6000 | 420000 |
S-HNI (Max) | 7 | 14000 | 980000 |
B-HNI (Min) | 8 | 16000 | 1120000 |
Aptus Pharma IPO Dates
IPO Activity | Date |
---|---|
Open Date: | 23 September, 2025 |
Close Date: | 25 September, 2025 |
Allotment Date: | 26 September, 2025 |
Refund Date: | 29 September, 2025 |
Shares Credit Date: | 29 September, 2025 |
Listing Date: | 30 September, 2025 |
Aptus Pharma Company Financial Report
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
---|---|---|---|
Assets | 21.92 | 10.03 | 6.22 |
Total Income | 24.64 | 17.88 | 13.90 |
Profit After Tax | 3.10 | 0.80 | 0.19 |
EBITDA | 4.76 | 1.49 | 0.57 |
Net Worth | 6.97 | 1.77 | 0.97 |
Reserves and Surplus | 1.97 | 1.47 | 0.67 |
Total Borrowing | 10.36 | 5.31 | 2.21 |
Amount in ₹ Crore |
Aptus Pharma Company Address
Company | Aptus Pharma Ltd. |
---|---|
Address | Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427 |
Phone | +91 76004 27827 |
info@aptuspharma.com | |
Website | https://aptus-pharma.com/ |
Aptus Pharma IPO Registrar
Company | Bigshare Services Pvt.Ltd. |
---|---|
Phone | +91-22-6263 8200 |
ipo@bigshareonline.com | |
Website | https://ipo.bigshareonline.com/IPO_Status.html |
Aptus Pharma IPO Lead Manager
- Interactive Financial Services Ltd.
Aptus Pharma IPO KPI
KPI | Values |
---|---|
ROE | 44.50% |
ROCE | 45.66% |
Debt/Equity | 1.49 |
RoNW | 44.50% |
EBITDA Margin | 19.31% |
Aptus Pharma IPO - FAQs
Q.What is Aptus Pharma IPO?
Ans.Aptus Pharma IPO is a SME IPO. The IPO is list on BSE SME. The total amount Aptus Pharma aim to raise is 18,60,000 shares (aggregating up to ₹13.02 Cr).
Q.When Aptus Pharma IPO will open?
Ans.Aptus Pharma IPO is to open on 23 September, 2025 for Investors.
Q.What is Aptus Pharma IPO Investors Portion?
Ans.Aptus Pharma investor's portion for QIB is 47.31%, NII is 14.30%, and Retail is 33.33%.
Q.What is Aptus Pharma IPO Size?
Ans.Aptus Pharma IPO size is 18,60,000 shares (aggregating up to ₹13.02 Cr).
Q.What is Aptus Pharma IPO Price Band?
Ans.Aptus Pharma IPO Price Band is ₹65 to ₹70 per share.
Q.What is the Aptus Pharma IPO Allotment Date?
Ans.Aptus Pharma IPO allotment date is 26 September, 2025.
Q.What is the Aptus Pharma IPO Listing Date?
Ans.Aptus Pharma IPO listing date is 30 September, 2025. The IPO is to list on BSE SME.